Interference with Oral Anticoagulant Treatment by Oestrogen – Influence of Oestrogen Administration Route

Thromb Haemost 1999; 81(03): 471-472
DOI: 10.1055/s-0037-1614503

Letters to the Editor

Schattauer GmbH

Authors

Frédéric Cotton

¹From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium
Philippe Sorlin

¹From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium
Bernard Corvilain

²Departments of Endocrinology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
Jean-Marie Fockedey

¹From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium
Paul Capel

¹From the Departments of Clinical Pathology and of Université Libre de Bruxelles, Brussels, Belgium

References
1 Kroon U-B, Silfverstolpe G, Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb Haemost 1994; 71: 420-3.
2 Scarabin P-Y, Plu-Bureau G, Bara L, Bonithonn-Kopp C, Guize L, Samama MM. Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemost 1993; 70: 584-7.
3 Pacifici GM, Viani A, Rizzo G, Carrai M. Plasma protein binding of ethinyloestradiol: effect of disease and interaction with drugs. Int J Clin Pharmacol Ther Toxicol 1989; 27: 362-5.
4 De Lignieres B, Basdevant A, Thomas G, Thalabard J-C, Mercier-Bodard C, Conard J, Guyene T-T, Mairon N, Corvol P, Guy-Grand B, MauvaiS-Jarvis P, Sitruk-Ware R. Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 1986; 62: 536-41.
5 De Teresa E, Vera A, Ortigosa J, Alonso Pulpon L, Puente Arus A, De Artaza M. Interaction between anticoagulants and contraceptives: an unsuspected finding. Br Med J 1979; 2: 1260-1.